Maplight Therapeutics CSO Lillie James Woodruff sells 22,082 shares for $276,908.28

• Maplight Therapeutics Chief Scientific Officer Lillie James Woodruff sold 22,082 shares of voting common stock on Aug. 3.
• Shares sold at a weighted average price of $12.54.
• Beneficial ownership fell to 202,380 shares following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001728746-26-000014), on August 04, 2026, and is solely responsible for the information contained therein.